阿德拉與莫達非尼:它們如何比較?

Adderall

Adderall is the brand name for a combination form of two drugs: amphetamine and dextroamphetamine. The drug combination has been approved by the U.S. Food and Drug Administration (FDA) to treat attention deficit hyperactivity disorder (ADHD) and the sleep disorder narcolepsy, a disorder in which patients may experience sleep disturbances during the day and during activities. Onset of illness) driving). The two main ingredients in Adderall are both central nervous system stimulants.

Adderall is available in an immediate-release form (Adderall IR) and an extended-release form (Adderall XR). The immediate-release form of the drug lasts about 4-6 hours; the extended-release form usually lasts about 12 hours.

Adderall is classified as a Schedule II controlled substance. Therefore, it is considered to carry a significant risk of abuse and physical dependence.

Modafinil

Modafinil, better known by the brand name Provigil, is also a CNS stimulant drug. Modafinil, often called a high-potency drug, is a drug that promotes alertness and wakefulness. Modafinil is FDA-approved to treat daytime sleepiness in people with a number of different conditions, including:

  • narcolepsy
  • Shift work disorder, a formal disorder involving disruption of normal sleep schedules while working at night
  • Drowsiness seen in other conditions, such as obstructive sleep apnea

Modafinil is also a controlled substance, but is much less controlled/severe than Adderall. Modafinil is classified as a Schedule IV controlled substance. The differences in the formal classifications of Adderall and Modafinil suggest that overall research and federal opinion are that Adderall is a more dangerous drug of abuse than Modafinil.

All stimulant drugs have a similar mechanism of action. Therefore, even when comparing prescription stimulants such as modafinil, which are considered relatively mild, to stimulants with significant abuse potential, such as cocaine, the findings suggest that these drugs have similar mechanisms of action. Some sources will attempt to capitalize on this finding, stating that similar mechanisms of action suggest similar potential for abuse; however, this is not always the case.

It is believed that Adderall actually increases intracellular production of the excitatory neurotransmitters dopamine and norepinephrine by blocking the reuptake of these neurotransmitters and by releasing these neurotransmitters from their storage units in neurons. concentration to exert its effect. Modafinil is also thought to affect several different neurotransmitters, including excitatory neurotransmitters such as dopamine and glutamate (increasing their availability), and decreasing inhibitory neurotransmitters such as gamma-aminobutyric acid (GABA) availability.

off-label uses

Despite their approved uses, these drugs are often prescribed for uses for which they are not formally approved. This is true for many different types of medications.

Off-label uses of Adderall are intended to take advantage of its stimulant effects. Adderall can be used to manage weight, increase alertness, and address obesity.

Modafinil is also used to treat conditions that its stimulating effects may treat, including treating various neurological disorders (such as multiple sclerosis or Parkinson's disease), fatigue and sleepiness in cancer patients, and even treating clinical depression in patients. of fatigue.

Modafinil is a much milder stimulant than Adderall, and its mild stimulant properties allow it to be used in a variety of situations to address drowsiness and sleepiness without causing anxiety, nervousness, irritability, or agitation. Adderall is a stronger stimulant and must be used in moderation.

Modafinil is not approved for the treatment of ADHD; however, it can be used off-label for this purpose. As of this writing, there are a few small controlled studies showing that modafinil is an effective treatment for ADHD. Research shows modafinil:

May be more effective than placebo in treating ADHD symptoms.
It may be as effective as methylphenidate (eg, Ritalon, Concerta) in treating ADHD, but with fewer side effects.
Compared with dextroamphetamine (an ingredient in Adderall), it may be equally effective in treating ADHD.
It should be noted that modafinil is not a drug approved to treat ADHD. Insurance companies may not approve it for this purpose, so the cost of the drug may not be paid when prescribed for this purpose.

Review

All comments are moderated before being published

HealthyPIG Magazine

View all
用粟粉醃肉有乜科學根據?揭開中菜「滑肉」嘅秘密

用粟粉醃肉有乜科學根據?揭開中菜「滑肉」嘅秘密

前言:點解中餐炒肉咁滑? 好多香港人炒肉嘅時候都會發現,餐廳啲雞絲牛柳炒出嚟特別滑溜、唔鞋口。呢個秘密,唔喺高級食材,而係一個平凡但強大嘅材料——粟粉(Cornstarch)。 呢種技巧叫做**「走油前醃」或「滑油醃肉法」(Velveting)**,係中餐獨有技術之一,主要靠粟粉、蛋白、調味料...
咩係三價鐵(Fe³⁺)同二價鐵(Fe²⁺)?

咩係三價鐵(Fe³⁺)同二價鐵(Fe²⁺)?

當我哋講「鐵質」時,唔止係話有冇攝取足夠,而係講緊鐵喺人體內唔同形態(尤其係三價鐵 Fe³⁺ 同二價鐵 Fe²⁺)點樣被吸收、轉化、運輸同儲存,呢啲都深深影響生物可利用率

全面解構低鐵原因、病理機制及影響

全面解構低鐵原因、病理機制及影響

低鐵唔止係營養問題,仲可能係身體慢性警號

鐵質(iron)係人體不可或缺嘅微量元素,主要負責攜帶氧氣嘅血紅素(hemoglobin)製造、能量代謝、免疫調節等。當鐵質長期攝取不足、吸收差、或失去過多,就會導致「低鐵」(iron deficiency)甚至發展成「缺鐵性貧血」(iron deficiency anemia)。本文將從臨床醫學與分子生理角度,深入探討低鐵嘅成因、病理機制、生物轉化過程,以及其對人體造成嘅連鎖影響。

Obefazimod(ABX464):潰瘍性結腸炎新藥研究、作用機制與研發進展

Obefazimod(ABX464):潰瘍性結腸炎新藥研究、作用機制與研發進展

Obefazimod(又名 ABX464)係由法國生物科技公司 Abivax 開發嘅口服小分子創新藥,目標治療慢性發炎性腸道疾病(IBD),特別係潰瘍性結腸炎(UC)同克羅恩氏病(CD)患者。

夢遺係唔係一定關性事?

夢遺係唔係一定關性事?

夢遺,即係在無意識之下於睡眠中射精,係一種常見於青春期男生甚至成年男性身上的自然生理現象。夢遺唔等於一定發生性夢,也唔等於有性慾過強。它與睡眠週期中快速動眼期(REM sleep)嘅勃起模式有關,亦可能反映正常的荷爾蒙波動及精液排出節律。 咩係夢遺? 夢遺(nocturnal emission...
唔凍都會打冷震?

唔凍都會打冷震?

打冷震(shivering)唔一定因為天氣凍,喺情緒波動、發燒初期、焦慮、緊張等情況下都可以出現。打冷震係一種由大腦下視丘控制嘅「非意識性肌肉收縮」,目的係維持或調節核心體溫或應對突發壓力。了解打冷震背後嘅神經與體溫調節原理,可以幫我哋區分「正常生理反應」同「潛在疾病警號」。 打冷震係乜回事...
一緊張就流手汗?

一緊張就流手汗?

手掌汗腺主要受交感神經系統控制。當人面對壓力、驚訝、社交場合等刺激時,大腦會啟動「戰鬥或逃跑反應」,促使手掌、腳底等部位產生明顯出汗。這種情況屬於精神性出汗,與溫度無直接關係,係身體對外在壓力的自然反應。

起身「眼前一黑」係咩事?

起身「眼前一黑」係咩事?

當你由坐或瞓姿突然企起,血液未能即時供應足夠氧氣到腦部,形成姿勢性低血壓(orthostatic hypotension),導致短暫性視野模糊、頭暈甚至站立不穩。青少年、長者、飲水不足或患有自律神經功能障礙人士較常出現。

瞓覺點解會流口水?

瞓覺點解會流口水?

唾液分泌受副交感神經控制,當身體進入深層睡眠並肌肉放鬆時,容易出現流口水現象,尤其側睡或口微開者更明顯。